Skip to main content

Table 6 SPIRIT diagram for both randomisation arms and intervention arm sub-groups

From: A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial

Back to article page

Trials

ISSN: 1745-6215